Trexquant Investment LP Pulmonx Corp Transaction History

Trexquant Investment LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$7.89 - $13.14 $84,107 - $140,072	-10,660 Reduced 29.95%	24,936 $317,000
Q3 2023 Nov 13, 2023	BUY	$9.88 - $14.0 $351,688 - $498,344	35,596 New	35,596 $367,000
Q2 2022 Aug 11, 2022	SELL	$14.0 - $27.95 $159,082 - $317,595	-11,363 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$21.13 - $35.65 $130,329 - $219,889	-6,168 Reduced 35.18%	11,363 $282,000
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $354,173 - $537,456	11,917 Added 212.27%	17,531 $562,000

Q3 2021 Nov 12, 2021	SELL	$35.98 - $44.48 $11,909 - $14,722	-331 Reduced 5.57%	5,614 $202,000
Q2 2021 Aug 12, 2021	SELL	$37.61 - $48.0 $85,713 - $109,392	-2,279 Reduced 27.71%	5,945 $262,000
Q1 2021 May 13, 2021	BUY	$44.0 - $67.54 $361,856 - $555,448	8,224 New	8,224 $376,000

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.